David Esposito

David Esposito serves as President and Chief Executive Officer at ONL Therapeutics. ONL Therapeutics operates in the research sector with approximately 42.0 employees. The company is headquartered in Ann Arbor, Michigan. ONL Therapeutics generates annual revenue of 11900000.0. To date, ONL Therapeutics has raised 149436109.0 in total funding, with the most recent round being Series D.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,434 executive contacts are available in Michigan.
• • Our database includes 201,469 c suite-level executives.

Outlook WordPress.org reCAPTCHA Nginx Gravity Forms Google Tag Manager Mobile Friendly Varnish Render Python Remote AI

ophthalmic drug development glaucoma geographic atrophy retinal detachment biotechnology life sciences biotechnology research biopharmaceutical retinal diseases ophthalmology clinical trials innovative therapeutics fas-mediated signaling neuroprotection peptide therapeutics onl1204 ocular diseases vision preservation macular degeneration glaucoma treatment orphan drug designation small peptide inhibitors inflammatory signaling neuroprotective technology vision restoration age-related macular degeneration investigational drug patient-centered care bioengineering toxicity assessments retinal cell protection clinical efficacy safety studies drug development therapeutic candidates disease modification clinical endpoints targeted therapies biotech investments research development regulatory compliance fda approvals medical innovation therapeutic efficacy patient recruitment commercialization strategies vision health healthcare solutions healthcare innovation stakeholder engagement fda designated investor confidence clinical study design drug discovery health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like David Esposito in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ONL Therapeutics.

David Esposito's Position in the MessageCEO Database

• •David Esposito is 1 of 1 verified executive contact we track at ONL Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •1,330 verified executive contacts in Michigan are in the database.
• •24 verified contacts work at research companies in the 42.0 employee range (same size as ONL Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach David Esposito directly?

David Esposito's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and Chief Executive Officer at ONL Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does David Esposito work for?

David Esposito is President and Chief Executive Officer at ONL Therapeutics, a company in the research sector with 42.0 employees. The company is based in Ann Arbor, Michigan.

Can I pitch or sell to David Esposito?

As President and Chief Executive Officer at ONL Therapeutics, David Esposito is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Esposito directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is David Esposito in?

David Esposito works in the research industry as President and Chief Executive Officer at ONL Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is David Esposito's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Esposito's profile is kept up-to-date with the latest available information.

Last updated: June 24, 2026